For these patients, the combination approach discussed earlier is more appropriate than a complete switch
2 In fact, according to Jaime Almandoz, MD, while more than 70 percent of U.S
Professional treatments deliver the dramatic, lasting results most patients seek for double chin removal or tighten skin under the chin but
"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026
The outer thigh is a fully approved and viable injection site, and many users prefer it to avoid stomach irritation
Other Weight Management Medications in Obese and Overweight Patients